Valentina Gelfanova
Eli Lilly (United States)(US)
Publications by Year
Research Areas
Mass Spectrometry Techniques and Applications, Alzheimer's disease research and treatments, Advanced Proteomics Techniques and Applications, Immune Cell Function and Interaction, T-cell and B-cell Immunology
Most-Cited Works
- → Nonsteroidal Anti-Inflammatory Drugs Can Lower Amyloidogenic Aß 42 by Inhibiting Rho(2003)308 cited
- → Comprehensive Label-Free Method for the Relative Quantification of Proteins from Biological Samples(2005)217 cited
- → Quantitative analysis of amyloid β peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry(2006)165 cited
- → A simplified procedure for the reduction and alkylation of cysteine residues in proteins prior to proteolytic digestion and mass spectral analysis(2004)130 cited
- → The impact of blood contamination on the proteome of cerebrospinal fluid(2004)123 cited
- → Cytolethal Distending Toxin ofHaemophilus ducreyiInduces Apoptotic Death of Jurkat T Cells(1999)96 cited
- → Macrophage-Mediated Degradation of β-Amyloid via an Apolipoprotein E Isoform-Dependent Mechanism(2009)66 cited
- → Expression of Cytolethal Distending Toxin and Hemolysin Is Not Required for Pustule Formation by Haemophilus ducreyi in Human Volunteers(2001)59 cited
- IL-15 promotes survival but not effector function differentiation of CD8+ TCRalphabeta+ intestinal intraepithelial lymphocytes.(1999)
- → IL-15 Promotes Survival But Not Effector Function Differentiation of CD8+ TCRαβ+ Intestinal Intraepithelial Lymphocytes(1999)49 cited